Literature DB >> 1102620

The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.

R E Jordon, J M Nordby, H Milstein.   

Abstract

By in vitro complement immunofluorescent staining methods, 46 serum samples from bullous pemphigoid patients with titers of antibasement-membrane-zone antibodies of 320 or greater were tested for their ability to fix C1q, C4, and C3. All three staining reactions were positive with 23 of the samples; 21 samples yielded negative reactions. With one sample, the C1q and C3 staining reactions were positive but the C4 reaction was negative; one other sample gave a positive C3 staining reaction only. Absorption of anti-C1q, anti-C4, and anti-C3 with C1q, C4, and C3, respectively, blocked the specific in vitro complement staining. Therefore, bullous pemphigoid antibodies of the IgG type appear to be capable of activating the "classical" complement pathway.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1102620

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  15 in total

1.  Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

Authors:  L Borrego; B Maynard; E A Peterson; T George; L Iglesias; M S Peters; W Newman; G J Gleich; K M Leiferman
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

2.  Complement fixation by Brazilian Pemphigus foliaceus autoantibodies.

Authors:  S Kawana; L A Diaz; E A Rivitti; W D Geoghegan; R E Jordon
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Capability of complement fixation of pemphigus antibodies in vitro.

Authors:  T Nishikawa; S Kurihara; T Harada; M Sugawara; H Hatano
Journal:  Arch Dermatol Res       Date:  1977-10-27       Impact factor: 3.017

4.  C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.

Authors:  G Tappeiner; K G Heine; J C Kahl; R E Jordon
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

5.  Capability of complement fixation of pemphigus antibodies in vitro.

Authors:  T Nishikawa; S Kurihara; T Harada; M Sugawara; H Hatano
Journal:  Arch Dermatol Res       Date:  1979-03-31       Impact factor: 3.017

6.  Studies on the immunologic aspects of keloids and hypertrophic scars.

Authors:  A M Janssen de Limpens; R H Cormane
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

7.  The immunopathology of herpes gestationis. Immunofluorescence studies and characterization of "HG factor".

Authors:  R E Jordon; K G Heine; G Tappeiner; L L Bushkell; T T Provost
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  Hereditary C2 deficiency and systemic lupus erythematosus associated with severe glomerulonephritis.

Authors:  J L Roberts; M M Schwartz; E J Lewis
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

9.  Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.

Authors:  Zhi Liu; Wen Sui; Minglang Zhao; Zhuowei Li; Ning Li; Randy Thresher; George J Giudice; Janet A Fairley; Cassian Sitaru; Detlef Zillikens; Gang Ning; M Peter Marinkovich; Luis A Diaz
Journal:  J Autoimmun       Date:  2008-10-14       Impact factor: 7.094

10.  Bullous pemphigoid autoantibodies reactive with intracellular basal keratinocyte antigens: studies of subclass distribution and complement activation.

Authors:  R E Jordon; P Xia; W D Geoghegan
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.